More Just Now Possible episodes
Published 19 Mar 2026
Duration: 3973
Medi-Bull leverages AI-driven automation to slash drug development timelines from over a decade to one year by streamlining clinical trial operations through document management, data integration, and patient engagement tools, with long-term goals of achieving fully autonomous trials via AI agents.
What if AI could help reduce the 10-plus years it takes to get a new drug to market? That's the driving ambition behind Medable's agentic platformand...
The podcast discusses Medi-Bull's mission to significantly reduce the time required to bring drugs to market by addressing inefficiencies in clinical trial operations. The company focuses on digitizing and automating processes such as clinical assessments, e-consent platforms, and patient participation tools. Its core solutions include the ETMF (Electronic Trial Master File) system for streamlining regulatory document management and the CRA Agent, a tailored tool for Clinical Research Associates to streamline data monitoring and issue detection across fragmented systems. Medi-Bulls Agent Platform, built on a SaaS model, enables users to create customizable agents using third-party models, retrieval-augmented generation (RAG), and data connectors, aiming to reduce manual tasks like document classification and metadata tagging, which currently consume over 5 minutes per document. The platform supports scalable deployment and integrates multiple data sources into a unified interface, with a focus on reusability and reducing cognitive load on users.
The podcast highlights challenges in clinical trials, including the administrative burden of managing tens of thousands of documents monthly, fragmented data systems requiring CRAs to juggle 13 separate tools, and the inefficiency of legacy platforms that lack actionable insights. Medi-Bulls AI-driven solutions aim to address these by automating document workflows and proactively identifying issues in real time, potentially cutting trial timelines from a decade to one year. The Agent Studio allows non-technical users to build agents with minimal guidance, emphasizing usability and flexibility, though challenges remain in data interoperability, context management, and ensuring regulatory compliance (e.g., GXP standards). Future goals include automating agent configuration, expanding self-learning capabilities for agents, and enabling fully autonomous clinical trial processes to accelerate drug development and improve patient safety.
5 Mar 2026 Building GitHub for Product Management: How Momental Uses AI to Find Merge Conflicts in Strategy
An AI-driven product management platform is being developed to automate tasks, enhance collaboration, and support data-driven decision-making for product managers.
19 Feb 2026 Building AI Sales Reps: How ShowMe Orchestrates Voice, Video, and Multi-Agent Workflows to Close Deals
ShowMe is a business AI platform that creates digital workers to assist in video calls, product demos, and sales tasks, aimed at high-quality leads and interactive experiences.
5 Feb 2026 Building Earmark: How a Two-Person Team Turned Meetings into Finished Work
The podcast transcription features repeated upbeat music cues without spoken dialogue or clear thematic content.
22 Jan 2026 When Trust Is Everything: Building AI for Physicians at Healio
Helio AI is a tool that fosters quick access to accurate medical information for healthcare professionals, providing evidence-based answers through a centralized platform built with a Retrieval-Augmented Generation (RAG) system.
15 Jan 2026 Building Tendos AI: How an Agent Swarm Turns Construction Emails into Quotes
A podcast examines the inefficiencies in construction industry back-office processes, particularly in the tendering chain, and how AI-powered automation can streamline tasks and improve accuracy and transparency.